Mirum Pharmaceuticals, Inc.MIRMNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

16 analysts·Moderate coverage

100%

Rating Distribution

Strong Buy

16%

Buy

1594%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case

$89.00

-14%

Consensus

$108.50

+5%

Bull Case

$140.00

+35%

Price Range16 analysts

Low

Consensus

High

$89.00

$140.00

Current Target

Current Price

$103.80

Upside to Target

$4.70

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-0.06(7 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+18.51%

EPS—

FY2028

Rev+27.38%

EPS+315.52%

FY2029

Rev+24.30%

EPS+89.87%

Earnings Surprises

Beat rate:50%(6/12 quarters)

Avg surprise:+5.1%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 26, 2026H.C. Wainwright

Mirum Pharmaceuticals price target raised to $130 from $102 at H.C. Wainwright

Target:$130.00

+37.9%from $94.29

Jan 20, 2026Evercore ISI

Mirum Pharmaceuticals price target raised to $101 from $94 at Evercore ISI

Target:$101.00

+10.8%from $91.13

Jan 13, 2026H.C. Wainwright

Mirum Pharmaceuticals price target raised to $102 from $81 at H.C. Wainwright

Target:$102.00

+14.0%from $89.50

Jan 12, 2026Robert W. Baird

Mirum price target raised at Baird after preliminary results

Target:$95.00

+6.1%from $89.50

Dec 19, 2025UBS

Mirum (MIRM) PT Raised to $140 at Citizens: Outperformance Expected

Target:$140.00

+99.2%from $70.28

Dec 11, 2025Raymond James

Mirum Pharmaceuticals (MIRM) PT Raised to $110 at Raymond James

Target:$110.00

+68.9%from $65.12

Dec 10, 2025Leerink Partners

Mirum Pharmaceuticals price target raised to $100 from $90 at Leerink

Target:$100.00

+54.6%from $64.67

Dec 9, 2025Morgan Stanley

Mirum Pharmaceuticals price target raised to $95 from $81 at Morgan Stanley

Target:$95.00

+38.1%from $68.81

Dec 8, 2025Evercore ISI

Mirum Pharmaceuticals price target raised to $94 from $89 at Evercore ISI

Target:$94.00

+38.4%from $67.90

Dec 8, 2025Robert W. Baird

Mirum Pharmaceuticals (MIRM) PT Raised to $88 at Baird

Target:$88.00

+29.6%from $67.90

Dec 8, 2025Cantor Fitzgerald

Mirum Pharmaceuticals price target raised to $130 from $95 at Cantor Fitzgerald

Target:$130.00

+94.2%from $66.95

Nov 5, 2025Cantor Fitzgerald

Mirum Pharmaceuticals price target raised to $95 from $85 at Cantor Fitzgerald

Target:$95.00

+36.2%from $69.77

Nov 5, 2025H.C. Wainwright

Mirum Pharmaceuticals price target raised to $81 from $80 at H.C. Wainwright

Target:$81.00

+14.1%from $70.97

Nov 5, 2025JMP Securities

Mirum Pharmaceuticals price target raised to $95 from $81 at Citizens JMP

Target:$95.00

+33.9%from $70.97

Oct 16, 2025Morgan Stanley

Mirum Pharmaceuticals price target raised to $81 from $75 at Morgan Stanley

Target:$81.00

+6.3%from $76.19

Aug 11, 2025Stifel Nicolaus

Stifel Resumes Mirum Pharmaceuticals (MIRM) at Buy, PT $89, 'stands out in what remains a discerning biotech tape'

Target:$89.00

+48.4%from $59.97

Aug 7, 2025JMP Securities

Mirum Pharmaceuticals price target raised to $81 from $79 at Citizens JMP

Target:$81.00

+35.4%from $59.82

Nov 12, 2024Stifel Nicolaus

Mirum Pharamceuticals (MIRM) PT Raised to $70 at Stifel

Target:$70.00

+72.6%from $40.55

Aug 8, 2024Robert W. Baird

Mirum Pharmaceuticals price target raised to $44 from $39 at Baird

Target:$44.00

+12.9%from $38.96

Jun 17, 2024Evercore ISI

Mirum Pharamceuticals (MIRM) PT Raised to $62 at Evercore ISI

Target:$62.00

+87.9%from $33.00

Jun 17, 2024Morgan Stanley

Mirum Pharamceuticals (MIRM) PT Raised to $57 at Morgan Stanley

Target:$57.00

+72.7%from $33.00

Jun 17, 2024H.C. Wainwright

Mirum Pharmaceuticals price target raised to $66 from $58 at H.C. Wainwright

Target:$66.00

+113.0%from $30.99

Jun 17, 2024Robert W. Baird

Mirum Pharamceuticals (MIRM) PT Raised to $39 at Baird

Target:$39.00

+31.3%from $29.71

May 23, 2024Cantor Fitzgerald

Mirum Pharmaceuticals price target raised to $45 from $40 at Cantor Fitzgerald

Target:$45.00

+74.8%from $25.75

Apr 16, 2024Stifel Nicolaus

Mirum Pharmaceuticals initiated with a Buy at Stifel

Target:$48.00

+99.9%from $24.01

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance